• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Indivior Pharmaceuticals, Inc. - Common Stock (NQ:INDV)

    34.74 +1.16 (+3.45%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,125,186
    Open 33.58
    Bid (Size) 33.49 (200)
    Ask (Size) 36.35 (100)
    Prev. Close 33.58
    Today's Range 33.54 - 34.94
    52wk Range 7.620 - 38.00
    Shares Outstanding 129,000,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) Presents a High-Growth Momentum Breakout Setup ↗
    Via Chartmill
    News headline image
    Indivior Announces Completion of Redomiciliation to the United States
    From Indivior Pharmaceuticals Inc.
    Via GlobeNewswire

    Performance

    YTD
    -2.8%
    -2.8%
    1 Month
    -4.4%
    -4.4%
    3 Month
    +39.5%
    +39.5%
    6 Month
    +101.0%
    +101.0%
    1 Year
    +189.0%
    +189.0%

    More News

    Read More
    News headline image
    Indivior Provides Full-Year 2026 Financial Guidance and Business Update
    From Indivior Inc.
    Via GlobeNewswire
    News headline image
    Mangrove Partners Loads Up Flywire With 2.9 Million Shares ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Earnings Scheduled For October 30, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For July 31, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For April 24, 2025 ↗
    Via Benzinga
    News headline image
    A Look at Indivior's Upcoming Earnings Report ↗
    Via Benzinga
    News headline image
    INDIVIOR PLC (NASDAQ:INDV) Presents a High-Growth Momentum and Technical Breakout Setup ↗
    Via Chartmill
    News headline image
    This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Bardin Hill Dumps 349,000 Shares of Frontier Communicaitons Stock Worth $12.7 Million ↗
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance
    News headline image
    Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock ↗
    Via The Motley Fool
    News headline image
    Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs ↗
    Via The Motley Fool
    News headline image
    The Remitly Reassessment: What Divisadero’s 95 Million Exit Tells Us About Digital Money Movement ↗
    Via The Motley Fool
    News headline image
    Here's Why Indivior Stock Soared 15% Today ↗
    Via The Motley Fool
    News headline image
    INDIVIOR PLC (NASDAQ:INDV) Shows Top Technical and Setup Ratings for Potential Breakout ↗
    Via Chartmill
    News headline image
    This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
    Via Benzinga
    News headline image
    Indivior (INDV) Q2 EPS Jumps 104% ↗
    Via The Motley Fool
    News headline image
    Roblox, Carvana, eBay, C.H. Robinson Worldwide, Huntington Ingalls Industries And Other Big Stocks Moving Higher On Thursday ↗
    Via Benzinga
    News headline image
    Indivior (INDV) Q1 2025 Earnings Call ↗
    Via The Motley Fool
    News headline image
    Indivior PLC: Is This Deeply Undervalued Stock A Hidden Gem? ↗
    Via Talk Markets
    Topics Stocks / Equities
    News headline image
    European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat ↗
    Via Benzinga
    News headline image
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill

    Frequently Asked Questions

    Is Indivior Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Indivior Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Indivior Pharmaceuticals, Inc. - Common Stock trade on?
    Indivior Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Indivior Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Indivior Pharmaceuticals, Inc. - Common Stock is INDV on the Nasdaq Stock Market
    What is the current price of Indivior Pharmaceuticals, Inc. - Common Stock?
    The current price of Indivior Pharmaceuticals, Inc. - Common Stock is 34.74
    When was Indivior Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Indivior Pharmaceuticals, Inc. - Common Stock was at 01/27/26 04:00 PM ET
    What is the market capitalization of Indivior Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Indivior Pharmaceuticals, Inc. - Common Stock is 4.48B
    How many shares of Indivior Pharmaceuticals, Inc. - Common Stock are outstanding?
    Indivior Pharmaceuticals, Inc. - Common Stock has 4B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.